A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB)

• Main Authors: Gary S. Marshall (Author), Victoria Abbing-Karahagopian (Author), Helen S. Marshall (Author), Silvia Cenci (Author), James H. Conway (Author), Emilia Occhipinti (Author), Rafik Bekkat-Berkani (Author), Angelika Banzhoff (Author), Woo-Yun Sohn (Author)
• Formato: Livro
• Publicado em: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Introduction Neisseria meningitidis causes invasive meningococcal disease and, globally, significant morbidity, with serogroup B (MenB) being the most common cause of endemic disease and outbreaks in several regions. Extensive use of the four-component serogroup B meningococcal vaccine (4CMenB; Bexs...